Detecting EGFR Mutations in Patients with Non-small Cell Lung Cancer

Mutations in the receptor of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) are used as biomarkers for predicting the response of treatment with EGFR tyrosine kinase inhibitors (EGFR TKIs). Non-small cell lung cancer patients usually have activating EGFR mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammoudeh, ZA, Antonova, O, Staneva, R, Nikolova, D, Kyuchukov, Y, Penev, A, Mintchev, T, Koleva, V, Hadjidekova, S, Toncheva, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231315/
https://www.ncbi.nlm.nih.gov/pubmed/30425905
http://dx.doi.org/10.2478/bjmg-2018-0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231315/
https://www.ncbi.nlm.nih.gov/pubmed/30425905
http://dx.doi.org/10.2478/bjmg-2018-0013

Ejemplares similares